NOUV — Nouveau Life Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $0.33m
Annual balance sheet for Nouveau Life Pharmaceuticals, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2003 June 30th | 2004 June 30th | 2005 June 30th | 2006 June 30th | 2007 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.001 | 0.008 | 0.001 | 0.004 | 0.004 |
Prepaid Expenses | |||||
Total Current Assets | 0.001 | 0.008 | 0.001 | 0.03 | 0.004 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | — | — | 0.82 |
Net Intangible Assets | |||||
Total Assets | 0.001 | 0.008 | 0.001 | 0.03 | 1.33 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.578 | 0.624 | 0.738 | 0.675 | 0.781 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.578 | 0.624 | 0.738 | 0.675 | 0.791 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.576 | -0.616 | -0.737 | -0.646 | 0.538 |
Total Liabilities & Shareholders' Equity | 0.002 | 0.008 | 0.001 | 0.029 | 1.33 |
Total Common Shares Outstanding |